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OBJECTIVES This study evaluated the determinants of coronary blood flow following thrombolytic
administration in a large cohort of patients.
BACKGROUND Tighter residual stenoses following thrombolysis have been associated with slower coronary blood
flow, but the independent contribution of other variables to delayed flow has not been fully
explored.
METHODS The univariate and multivariate correlates of coronary blood flow at 90 min after thrombolytic
administration were examined in a total of 2,195 patients from the Thrombolysis in
Myocardial Infarction (TIMI) 4, 10A, 10B and 14 trials. The cineframes needed for dye to
first reach distal landmarks (corrected TIMI frame count, CTFC) were counted as an index
of coronary blood flow.
RESULTS The following were validated as univariate predictors of delayed 90-min flow in two cohorts of
patients: a greater percent diameter stenosis (p , 0.0001 for both cohorts), a decreased minimum
lumen diameter (p 5 0.0003, p 5 0.0008), a greater percent of the culprit artery distal to the
stenosis (p 5 0.03, p 5 0.02) and the presence of any of the following: delayed achievement of
patency (i.e., between 60 and 90 min) (p , 0.0001 for both cohorts), a culprit location in the left
coronary circulation (left anterior descending or circumflex) (p 5 0.02, p , 0.0001), pulsatile flow
(i.e., reversal of flow in systole, a marker of heightened microvascular resistance, p 5 0.0003, p ,
0.0001) and thrombus (p 5 0.002, p 5 0.03). Despite a minimal 16.4% residual stenosis following
stent placement, the mean post-stent CTFC (25.8 6 17.2, n 5 181) remained significantly slower
than normal (21.0 6 3.1, n 5 78, p 5 0.02), and likewise 34% of patients did not achieve a CTFC
within normal limits (i.e., ,28 frames, the upper limit of the 95th percent confidence interval
previously reported for normal flow). Those patients who failed to achieve normal CTFCs
following stent placement had a higher mortality than did those patients who achieved normal
flow (6/62 or 9.7% vs. 1/118 or 0.8%, p 5 0.003).
CONCLUSIONS Lumen geometry is not the sole determinant of coronary blood flow at 90 min following
thrombolytic administration. Other variables such as the location of the culprit artery, the
duration of patency, a pulsatile flow pattern and thrombus are also related to slower flow.
Despite a minimal 16% residual stenosis, one-third of the patients treated with adjunctive
stenting still have a persistent flow delay following thrombolysis, which carries a poor prognosis.
(J Am Coll Cardiol 1999;34:1403–12) © 1999 by the American College of Cardiology
Coronary blood flow is a major determinant of clinical
outcomes in patients with acute myocardial infarction
(AMI) (1–7). To guide therapy better, further insight into
the determinants of coronary blood flow is needed. The
conventional Thrombolysis in Myocardial Infarction
(TIMI) flow grade classification scheme (1) has been a
valuable tool to compare angiographic and clinical outcomes
following thrombolysis (2–7). This classification scheme is
limited, however, by interobserver variability, its categorical
nature, its limited statistical power, and the fact that
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nonculprit flow (used to gauge TIMI flow grade 3) is
abnormally slow early in the course of AMI (8). Use of the
Doppler velocity wire in a very large number of patients is
limited by the need to instrument the artery in patients who
may not require intervention.
Recently we described a new index of coronary blood flow
called the corrected TIMI frame count (CTFC) in which
the number of frames required for dye to first reach
standardized distal landmarks is counted (8). Although
tighter residual stenoses following thrombolysis have been
associated with slower flow (9,10), the independent contri-
bution of other angiographic, hemodynamic and clinical
findings to delayed flow has not been fully evaluated. The
goal of this study was to identify and validate the indepen-
dent predictors of coronary blood flow following thrombo-
lytic administration in over 2,000 patients, the largest series
described to date by a single reader.
METHODS
Corrected TIMI frame count data was pooled from the
TIMI 4, 10A, 10B, and 14 trials. The TIMI 4 trial was a
randomized double-blind comparison of three thrombolytic
regimens (11): antistreplase (Eminase) versus front-loaded
recombinant tissue plasminogen activator (rt-PA) (Activase
or alteplase) versus combination therapy in 416 patients.
The TIMI 10A trial was a nonrandomized, open-label,
dose-escalation study of eight ascending doses of TNK (a
mutant of recombinant tissue plasminogen activator) (5,
7.5, 10, 15, 20, 30, 40, 50 mg IV over 5 s) in 113 patients
(12). TIMI 10B was an 880-patient randomized trial
comparing 30, 40 and 50 mg of TNK versus front-loaded
rt-PA (13). Data from 812 patients enrolled in the ongoing
TIMI 14 trial comparing abciximab versus abciximab 1 a
low-dose thrombolytic were also included (14). Angiogra-
phy was performed at 60, 75 and 90 min following throm-
bolytic administration (8,11–13). Nitroglycerin (IV or sub-
lingual) was administered every 15 min if the systolic blood
pressure exceeded 110 mm Hg (8,11–13). Hemodynamics
were evaluated at 90 min following thrombolysis in patients
enrolled in the TIMI 14 trial. Few patients had a Fick
cardiac output measured; therefore, the ventriculographic
cardiac output was also estimated as stroke volume 3 heart
rate at 90 min. The TIMI studies were approved by each
participating center’s Institutional Review Board, and the
trial was conducted according to the principles of the
Declaration of Helsinki.
Angiographic analysis methods. The TIMI flow grade
was assessed as previously defined at the TIMI Angio-
graphic Core Laboratory (1). To evaluate objectively coro-
nary flow as a continuous quantitative variable, the number
of cineframes required for contrast to first reach standard-
ized distal coronary landmarks in the infarct-related artery
(the TIMI frame count) was measured using a frame
counter on a cineviewer (8). Data presented here have been
converted to and are reported using the most common
cinefilming speed in the U.S.: 30 frames/s (15). All flow
data was assessed by a single observer (CMG). A pulsatile
flow pattern was defined as intermittent cessation of ante-
grade flow or frank flow reversal during systole. The optimal
single-plane projection was selected that identified the
stenosis in its greatest severity with minimal foreshortening
or overlapping of branches, and end-diastolic frames were
chosen for quantitative angiographic analysis using a previ-
ously described and validated automated edge-detection
algorithm (16).
Statistical analysis. All analyses were performed using
Stata version 5.0 (17). All continuous variable values are
reported as the mean 6 standard deviation. Analysis of
variance (ANOVA), with a Bonferroni correction for mul-
tiple corrections or multiple linear regression, was utilized
for the analysis of continuous variables. A p value ,0.10 was
required for retention in step-up linear regression models.
The nonparametric Wilcoxon rank-sum test was used when
the data were not normally distributed or when data were
imputed to an occluded vessel. When appropriate, the
chi-square test or logistic regression was used for analysis of
categorical variables when appropriate. Patient identifica-
tion numbers were randomized into two random cohorts,
and the univariate and multivariate correlates were validated
independently in the two cohorts.
RESULTS
Relationship of TIMI flow grades 2 and 3 to angio-
graphic and hemodynamic variables. To gain further
insight into the correlates of the conventional TIMI flow
grades 2 and 3, their relationships to a variety of
angiographic and hemodynamic variables were examined.
The CTFC of patients with TIMI flow grade 2 was more
than twice that of patients with TIMI flow grade 3
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
ANOVA 5 analysis of variance
CTFC 5 corrected Thrombolysis in Myocardial Infarc-
tion frame count. (Number of frames
required for dye to reach a standardized
distal landmark)
LAD 5 left anterior descending artery
PAMI 5 Primary Angioplasty in Myocardial Infarc-
tion
PTCA 5 percutaneous transluminal coronary
angioplasty
RCA 5 right coronary artery
rt-PA 5 recombinant tissue plasminogen activator
TIMI 5 Thrombolysis in Myocardial Infarction
TNK 5 a mutant of recombinant tissue
plasminogen activator
1404 Gibson et al. JACC Vol. 34, No. 5, 1999
Predictors of Blood Flow After Thrombolysis November 1, 1999:1403–12
(Table 1), indicating a flow of less than half. Although no
difference existed in the normal reference segment diam-
eter between the two flow grades, the minimum lumen
diameter of patients with TIMI flow grade 2 was smaller
and the percent diameter stenosis was correspondingly
tighter than in patients with TIMI flow grade 3 (Table
1). Patients with TIMI flow grade 2 more often received
collaterals; they also had a higher proportion of left
anterior descending artery (LAD) lesions, a greater inci-
dence of both thrombus and pulsatile flow, a greater
percent of the culprit artery distal to the stenosis com-
pared with TIMI flow grade 3 but lower ejection frac-
tions (Table 1). Although no difference was seen between
TIMI flow grades 2 and 3 in the time from the onset of
symptoms to treatment, a greater proportion of patients
with TIMI flow grade 2 at 90 min were not open by
60 min (i.e., the duration of patency was ,30 min, p ,
0.0001) (Table 1). A lower systolic blood pressure was
Table 1. Relationship Among the TIMI Flow Grades, Hemodynamics, and Angiographic
Variables During Acute Myocardial Infarction
TIMI Flow
Grade 2
TIMI Flow
Grade 3
Two-Way
p Value
Corrected TIMI frame count* 62.1 6 27.1 26.6 6 9.0 , 0.0001
(n 5 430) (n 5 1,132)
Normal reference diameter (mm)* 3.11 6 0.93 3.11 6 0.88 NS
(n 5 466) (n 5 1,184)
Minimum diameter (mm)* 0.87 6 0.51 1.02 6 0.53 , 0.0001
(n 5 466) (n 5 1,184)
Percent diameter stenosis (%)* 71.1 6 15.7% 66.3 6 15.4% , 0.0001
(n 5 466) (n 5 1,184)
Duration of patency .30 min*
(i.e., patent at 60 min)
85.1% 94.7% , 0.0001
(n 5 276) (n 5 636)
Pulsatile flow† 22.2% 8.2% , 0.0001
(n 5 334) (n 5 959)
Thrombus* 25.8% 17.5% 0.0001
(n 5 472) (n 5 1,188)
Lesion length (mm) 8.8 6 6.6 7.9 6 5.7 0.09
(n 5 158) (n 5 439)
% Left-system lesions (%)* 67.7% 42.4% , 0.0001
(n 5 477) (n 5 1,200)
% Vessel distal to stenosis (%)† 71.0 6 17.8% 66.2 6 20.8% 0.0002
(n 5 320) (n 5 928)
Collaterals* 16.6% 10.8% 0.002
(n 5 415) (n 5 1,097)
Systolic blood pressure (mm Hg)§ 115.6 6 20.3 121.8 6 20.7 0.03
(n 5 72) (n 5 222)
Diastolic blood pressure (mm Hg)§ 68.4 6 12.6 69.9 6 12.4 NS
(n 5 71) (n 5 220)
Heart rate (beats/min)§ 78.8 6 19.4 80.5 6 15.7 NS
(n 5 61) (n 5 183)
Left ventricular ejection fraction at 90 53.9 6 15.0% 59.4 6 13.8% , 0.0001
min* (n 5 204) (n 5 617)
Ventriculographic cardiac output 4.6 6 2.2 6.5 6 4.2 0.04
(liter/min)§ (n 5 22) (n 5 68)
Left ventricular end diastolic pressure 19.9 6 8.1 17.2 6 7.3 0.06
(mm Hg)§ (n 5 37) (n 5 96)
Double product§ 9,164 6 2,396 9,894 6 2,600 0.06
(n 5 60) (n 5 175)
Time to treatment (h)‡ 3.3 6 2.0 3.3 6 1.9 NS
(n 5 269) (n 5 679)
Data presented as mean 6 SD for continuous variables or percent.
*Data available from TIMI 4, 10A, 10B and 14. †Data available from TIMI 10A, 10B and 14. ‡Data available from TIMI
4 and TIMI 10B. §Data available from TIMI 14.
The following differences between TIMI flow grades 2 and 3 were validated in two separate random cohorts: CTFC (p ,
0.0001 for both); minimum lumen diameter (p , 0.0001 and p 5 0.0005); percent diameter stenosis (p , 0.0001 and p 5
0.0004); duration of patency .30 min (p 5 0.01 and p , 0.0001); pulsatile flow (p , 0.0001 for both); the percent of left-system
lesions (p , 0.0001 for both); the percent vessel distal to stenosis (p 5 0.009 and p 5 0.006); the 90-min ejection fraction (p 5
0.01 and p 5 0.0001). There was a trend for the presence of thrombus to be valid in the two cohorts (p , 0.0001 and p 5 0.13).
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associated with arteries with TIMI flow grade 2, but no
differences existed in diastolic pressures between flow
grades (Table 1). Although the heart rate did not differ
between the two flow grades, the ventriculographic car-
diac output was lower in patients with TIMI flow grade
2 (Table 1). Patients with TIMI flow grade 2 tended to
have higher left ventricular end-diastolic pressures and
lower double products (90-min heart rate 3 90-min
blood pressure) (Table 1).
The following factors were validated as univariate predic-
tors of TIMI flow grade 2 in two random cohorts of
patients: smaller minimum lumen diameters, tighter percent
diameter stenoses, failure to achieve patency early by
60 min, a pulsatile flow pattern, a greater percent of the
culprit artery distal to the stenosis, the presence of a
left-system culprit lesion and the 90-min ejection fraction.
No difference existed between the two cohorts in height
(TIMI flow grade 2 5 170.6 6 9.4 cm [n 5 256] vs. TIMI
flow grade 3 5 171.1 6 9.5 cm [n 5 643], p 5 NS), weight
(79.3 kg for both, n 5 973), body surface area (3.76 m2 for
both, n 5 899), age (TIMI flow grade 2 5 58.9 6 11.8
years [n 5 308], TIMI flow grade 3 5 58.7 6 11.4 years
[n 5 744], p 5 NS) or gender (rate of TIMI flow grade 3
55.9% for men [n 5 803] and 55.2% for women [n 5 249]).
There was a tendency for current smokers to have a higher
rate of TIMI flow grade 3 (54.2% [n 5 177] vs. 44.3% [n 5
223; p 5 0.054]).
Response of TIMI flow grades 2 and 3 at 90 min to
adjunctive PTCA of the residual stenosis. To gain fur-
ther insight into the relative contribution of the epicardial
stenosis to the various TIMI flow grades, the response to
adjunctive (for TIMI flow grades 2 and 3) and rescue
percutaneous transluminal coronary angioplasty (PTCA)
(for TIMI flow grades 0 and 1) was examined (Fig. 1, Table
2). Although both successful adjunctive and rescue PTCA
largely normalized discrepancies in pre-PTCA CTFCs
among the TIMI flow grades at 90 min, it is notable that
neither adjunctive nor rescue PTCA restored a normal
CTFC to TIMI flow grades 0/1 (p 5 0.0005) or grade 2
(p 5 0.0003) following PTCA (i.e., mean post-PTCA
CTFCs were higher than a CTFC of 21.0 6 3.1 [n 5 78],
the previously reported normal CTFC observed in the
absence of acute MI [8]). In a paired analysis, adjunctive
PTCA of the culprit artery restored a culprit CTFC (30.5 6
23.1) that was the same as that in the nonculprit artery at
90 min (30.5 6 13.6, paired n 5 168, p 5 NS). However, both
post-PTCA culprit and nonculprit flows were 45% slower than
normal flow in the absence of AMI (21.0 6 3.1 [n 5 78] as
previously defined [8], p , 0.0005). Although patients with
TIMI flow grade 2 sustained a highly significant 47.0 6 40.3
frame improvement in the CTFC following adjunctive PTCA
(p , 0.0001), patients with TIMI flow grade 3 sustained a
significant but smaller improvement in their CTFC (27.8
frames pre-PTCA to 23.1 frames post-PTCA, p 5 0.02).
Figure 1. Impact of PTCA and intracoronary stenting following thrombolytic administration on coronary blood flow. The percent
distribution of the original 90-min TIMI flow grades among those patients who ultimately underwent stent placement is shown below the
bar diagram. To the right of each bar is the percent of patients who went on to develop each of the TIMI flow grades following PTCA
and stenting. For example, 34% of those patients who were stented had TIMI flow grade 0/1 at 90 min. Two percent of the patients who
began with TIMI flow grade 0/1 remained occluded following the conventional PTCA, 28% went on to develop TIMI flow grade 2, and
70% went on to develop TIMI flow grade 3 after conventional PTCA. Following stent placement, no patients had TIMI flow grade 0/1,
12% had TIMI flow grade 2, and 88% had TIMI flow grade 3. The sample size of patients with PTCA data is reduced because the
post-PTCA flow was not always filmed prior to stent placement.
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Placement of an intracoronary stent would be expected
not only to relieve the residual stenosis but also to minimize
the potential for intraluminal obstruction due to thrombus
and dissection planes and also to relieve laminar flow
disturbances (Fig. 1). In those patients in which both
post-PTCA and post-stent frame counts were available, the
CTFC improved by 4.1 6 15.1 frames (from 26.6 6 18.6 to
22.5 6 11.8, p 5 0.03, n 5 63) following intracoronary
stent placement in a paired analysis. Likewise, the rate of
TIMI flow grade 3 improved from 80% post-PTCA to 88%
following stent placement.
Despite a minimal 16.4 6 16.1% residual stenosis fol-
lowing stent placement, the mean post-stent CTFC re-
mained elevated, however, at 25.8 6 17.2 (n 5 181) frames
(p 5 0.02 vs. the previously defined normal value of 21.0 6
3.1 for normal flow [8]), and 34% of patients did not achieve
a CTFC within normal limits (i.e., ,28 frames, the upper
limit of the 95th percent confidence interval [CI] previously
reported [8] for normal flow). Those patients who failed to
achieve a CTFC within normal limits following stent
placement had a higher mortality than did those patients
who achieved normal flow (1/118 or 0.8% vs. 6/62 or 9.7%,
p 5 0.003).
Relationship of the 90-min-corrected TIMI frame count
to angiographic and hemodynamic variables. The rela-
tionship of a quantitative index of flow, the CTFC, to
angiographic and hemodynamic variables was also evalu-
ated. Tighter 90-min percent diameter stenoses and mini-
mum lumen diameters were both univariate correlates of
slower 90-min CTFCs (p , 0.001 for both) as was a longer
length of the lesion (p 5 0.006) (Table 3). An increased
percent of the artery distal to the culprit stenosis (i.e., a
more proximal lesion) was also associated with slower
90-min CTFCs (p 5 0.001).
The presence of the following categorical variables was
related to slower 90-min flow: failure to achieve patency
(TIMI flow grades 2 or 3) by 60 min after thrombolytic
administration (p , 0.0001), the presence of a pulsatile flow
pattern (p , 0.0001), the location of the culprit artery in the
left system (LAD or circumflex) (p , 0.0001), the presence
of thrombus (p 5 0.0002), and the presence of collaterals
(p 5 0.0003) (Table 3). The following variables were
validated as predictors of slower CTFCs in the two patients
cohorts: the 90-min percent stenosis (p , 0.0001 for both);
the 90-min minimum lumen diameter (p 5 0.0003 and p 5
0.0008); the percent of the culprit artery distal to the
stenosis (p 5 0.03 and p 5 0.02); the duration of patency
(p , 0.0001 for both); the presence of pulsatile flow (p 5
0.0003 and p , 0.0001); left-system infarct location (p 5
0.02 and p , 0.0001); and the presence of thrombus (p 5
0.002 and p 5 0.03). There was a tendency for the following
variables to be valid in the two separate random cohorts: the
90-min ejection fraction (p 5 0.06 and p 5 0.003); the
presence of collaterals (p 5 0.0002 and p 5 0.17); and the
ventriculographic cardiac output (p 5 0.13 and p 5 0.06).
There were only modest trends for the CTFC to be related
to weight (p 5 0.10, n 5 873), body surface area (p 5 0.08,
n 5 803) and current smoking status (36.3 6 15.7 [n 5 98]
vs. 41.4 6 22.0 [n 5 123], p 5 0.056), none of which were
valid in two separate cohorts.
Differences in outcomes among the three epicardial
culprit arteries. The CTFC was slowest for LAD and
circumflex culprit locations, and fastest for the right coro-
nary artery (RCA) (p , 0.0001 vs. CTFC of left system)
(Table 4). Likewise, the rate of TIMI flow grade 3 was
lower in arteries supplying the left ventricle than in those
supplying the right ventricle (p , 0.001). Minimum lumen
diameters were smaller in the left system, but so were the
normal reference segment diameters; consequently, percent
diameter stenosis (which is independent of arterial diame-
ter) did not differ between left and right systems. Left-
system lesions were located significantly more proximally
than in the right system (Fig. 2, p , 0.0001). Following
PTCA, the CTFC was slower for left-system culprit lesions
compared with RCA lesions (32.7 6 26.3 [n 5 117] vs.
25.5 6 17.7 [n 5 246], p 5 0.002), despite the fact that
Table 2. Corrected TIMI Frame Counts of the Various TIMI Flow Grades at 90 Min Following PTCA of the Residual Stenosis
Pre-PTCA TIMI
Flow Grade
Culprit
Pre-PTCA
CTFC
Culprit
Post-PTCA
CTFC
Nonculprit
Pre-PTCA
CTFC
Delta Culprit CTFC
(Pre-Post PTCA)
Post-PTCA
Percent Culprit
Stenosis
TIMI 0 or 1 — 29.1 6 20.0* 29.0 6 12.7 — 44.6 6 22.3%§
(n 5 192) (n 5 223) (n 5 280)
TIMI 2 68.5 6 31.0† 29.3 6 19.4* 34.6 6 18.2†† 47.0 6 40.3‡ 40.2 6 21.6%
(n 5 135) (n 5 67) (n 5 126) (n 5 66) (n 5 119)
TIMI 3 27.8 6 8.9† 23.1 6 20.6* 27.3 6 11.9 4.6 6 19.0‡ 38.2 6 18.1%
(n 5 172) (n 5 96) (n 5 132) (n 5 95) (n 5 134)
Data presented as mean 6 SD. Delta culprit CTFC is derived from film pairs.
†p , 0.0001 versus TIMI flow grade 3. *p 5 0.04 among the four TIMI flow grades. Versus a normal CTFC of 21.0 6 3.1 in 78 patients without AMI described previously
(8), p 5 0.0005 for TIMI flow grade 0/1 pre-PTCA, p 5 0.0003 for TIMI flow grade 2 pre-PTCA, and p 5 NS for TIMI flow grade 3 pre-PTCA. Stated in other terms,
the percent of patients with abnormal flow (defined as a CTFC $28 frames, the upper limit of the 95% CI for normal flow) following PTCA was as follows: TIMI flow grade
0/1 40.1%, TIMI flow grade 2 35.8%, TIMI flow grade 3 24.0%. ††p 5 0.0001 for nonculprit CTFCs in patients with TIMI flow grade 2 versus TIMI flow grade 3. ‡p ,
0.0001 for the change in CTFC pre- and post-PTCA for TIMI flow grade 2 and p 5 0.02 for the change in CTFC pre- and post-PTCA for TIMI flow grade 3. §p 5 0.07
for TIMI flow grade 0/1 versus TIMI flow grade 2, and p 5 0.005 versus TIMI flow grade 3. TIMI flow grades 2 and 3 do not differ from each other.
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there was no difference in percent diameter stenosis post-
PTCA (41.7 6 22.4%, n 5 255 vs. 42.0 6 20.0%, n 5 292,
p 5 NS).
Multivariable model of the 90-min CTFC. The final
multivariable model for the 90-min CTFC was as follows:
90-min CTFC 5 33.1 frames 1 5.0 frames if a left-system
lesion (p 5 0.002) 2 16.9 frames if open at 60 min (p ,
0.001) 1 0.21 frames 3 percent stenosis (p , 0.001) 1 8.5
frames if pulsatile flow was present (p , 0.001) (overall
model n 5 672, r 5 0.33). With the exception of left-
system location, each independent multivariable remained a
significant correlate of the 90-min CTFC when the model
was tested in two independent, random cohorts.
In a model that was restricted to those patients with
hemodynamic data available, systolic blood pressure (p 5
0.001) and left ventricular end-diastolic pressure (p 5
0.005) and ventriculographic cardiac output (p 5 0.078)
were also independent predictors of the 90-min CTFC in a
model that corrected for percent stenosis, left-system loca-
tion (p 5 0.012) and pulsatile blood flow (p 5 0.003). The
model that included hemodynamic data had the highest r2
of any model (r2 5 0.50, r 5 0.71, overall model p ,
0.0001, n 5 60).
DISCUSSION
Determinants of coronary blood flow at 90 min following
thrombolytic administration. Previous studies have iden-
tified the presence of a tighter residual stenosis as a potential
cause of TIMI flow grade 2 at 90 min following thrombo-
lytic administration (9,10). The present study confirms the
observation that increased residual stenosis severity is asso-
ciated with TIMI flow grade 2 and higher TIMI frame
counts. In addition to lumen geometry, however, the fol-
lowing were additional predictors of slower flow at 90 min:
Table 3. Univariate Predictors of 90-Min Flow (CTFC)
Continuous Variables
p Value
Number of
Observations t-Statistic
Correlation
Coefficient
90-min percent stenosis* 1,543 6.21 0.16 , 0.001
90-min minimum lumen
diameter (mm)*
1,543 24.83 20.12 , 0.001
90-min lesion length (mm)§ 589 2.78 0.11 0.006
Percent vessel distal to stenosis (%)† 1,231 3.19 0.09 0.001
Left ventricular end diastolic pressure
(mm Hg)§
131 1.98 0.17 0.05
Systolic blood pressure (mm Hg)§ 287 22.74 20.16 0.006
Double product§ 228 22.41 20.16 0.02
Ventriculographic§ cardiac output
(liter/min)
88 22.46 20.26 0.02
Left ventricular ejection fraction
at 90 min*
804 23.60 20.13 , 0.001
Categorical Variables
p ValuePresent Absent
Duration of patency (.30 min)* 34.5 6 19.4 54.9 6 38.8 , 0.0001
(n 5 782) (n 5 70)
Pulsatile† 45.4 6 26.2 34.4 6 21.8 , 0.0001
(n 5 151) (n 5 1,117)
Left-system* infarct location 39.3 6 21.4 33.6 6 23.4 , 0.0001
(n 5 755) (n 5 807)
Thrombus* 40.7 6 26.3 35.2 6 21.5 0.0002
(n 5 296) (n 5 1,253)
Collaterals* 41.8 6 26.7 35.2 6 22.1 0.0003
(n 5 176) (n 5 1,259)
Data for categorical variables presented as mean 6 SD.
*Data available from TIMI 4, 10A, 10B, and 14. †Data available from TIMI 10A, 10B, and 14. §Data available from TIMI
14.
The following variables were validated as associated with the CTFC in two separate random cohorts: the 90-min percent
stenosis (p , 0.0001 for both); the 90-min minimum lumen diameter (p 5 0.0003 and p 5 0.0008); the percent of patent distal
to the stenosis (p 5 0.03 and p 5 0.02); the duration of patency (p , 0.0001 for both); the presence of pulsatile flow (p 5 0.0003
and p , 0.0001); left-system infarct location (p 5 0.02 and p , 0.0001); the presence of thrombus (p 5 0.002 and p 5 0.03).
There was a tendency for the following variables to be valid in the two separate random cohorts: the 90-min ejection fraction
(p 5 0.06 and p 5 0.003); the ventriculographic cardiac output (p 5 0.13 and p 5 0.06); and collaterals (p 5 0.0002 and p 5
0.17).
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a shorter duration of patency (i.e., arteries closed at 60 min
that opened by 90 min had slower 90-min frame counts
than did those arteries that were open at 60 min); infarct
location (LAD or left-system infarcts); more proximal
infarcts with a greater percentage of the vessel distal to the
stenosis; thrombus; and the presence of a pulsatile flow
pattern (systolic flow reversal, a marker of heightened
microvascular tone, but which may also be observed in other
conditions such as hypertrophy). In those patients in whom
hemodynamic data were available from TIMI 14, lower
systolic arterial blood pressure, lower cardiac output and
higher left ventricular end-diastolic pressures were also
independently associated with slower flow. Current smok-
ing was the only clinical variable that tended to be associated
with more rapid flow, but smokers more often had RCA
infarcts, and the infarct location rather than smoking status
might account for the more rapid flow. The slower flow
observed in arteries that opened more recently may reflect
the fact that the transition from epicardial patency to
myocardial reperfusion (or transient no/slow reflow) might
also require more time with an increasing duration of
ischemia.
Table 4. Characteristics of Patent Culprit Arteries in the Setting of Acute MI by
Anatomic Location
LAD Circumflex RCA
90-min minimum lumen diameter 0.94 6 0.55 0.91 6 0.41 1.04 6 0.53
(mm)* (n 5 621) (n 5 195) (n 5 807)
90-min normal reference segment 2.97 6 0.87 3.10 6 0.92 3.23 6 0.87
diameter (mm)† (n 5 621) (n 5 195) (n 5 807)
90-min percent stenosisC 67.8 6 17.0% 69.5 6 13.5% 67.1 6 15.0%
(n 5 621) (n 5 195) (n 5 807)
90-min lesion length (mm)CC 7.6 6 5.1 7.6 6 6.5 8.7 6 6.5
(n 5 239) (n 5 67) (n 5 297)
Percent TIMI flow grade 3 at 46.0% 56.4% 64.2%
90 min†† (n 5 778) (n 5 264) (n 5 1,044)
90-min CTFC (frames)§ 39.1 6 21.7 40.4 6 20.5 33.4 6 23.5
(n 5 578) (n 5 177) (n 5 784)
Percent thrombus at 90 min¶¶ 17.0% 17.0% 22.7%
(n 5 628) (n 5 194) (n 5 809)
Length of vessel proximal to 3.6 6 2.2 4.2 6 2.7 5.0 6 3.3
stenosis (cm)‡ (n 5 492) (n 5 152) (n 5 638)
Length of vessel distal to stenosis 11.8 6 3.2 9.2 6 3.1 7.8 6 3.9
(cm)** (n 5 500) (n 5 161) (n 5 649)
Percent of vessel distal to stenosis¶ 76.6 6 10.9% 70.1 6 18.4% 59.8 6 23.3%
(n 5 403) (n 5 124) (n 5 512)
Percent of vessel with pulsatile flow 18.7% 6.7% 6.0%
pattern¥ (n 5 576) (n 5 208) (n 5 797)
90-min systolic blood pressure 121.7 6 19.9 120.6 6 22.0 120.2 6 21.6
(mm Hg)‡‡ (n 5 139) (n 5 39) (n 5 169)
90-min left ventricular end diastolic 19.7 6 8.0 18.0 6 8.3 16.4 6 6.8
pressure (mm Hg)§§ (n 5 57) (n 5 9) (n 5 61)
Post-PTCA CTFC¥¥ 30.0 6 16.3 36.5 6 36.1 25.5 6 17.7
(n 5 69) (n 5 48) (n 5 246)
*p 5 NS for LAD versus Cx; p 5 0.0004 for LAD versus RCA; p 5 0.001 for Cx versus RCA; LAD & Cx combined 5 0.93 6
0.52, n 5 816, p 5 0.0001 versus RCA. †p 5 0.06 for LAD versus Cx; p , 0.0001 for LAD versus RCA; p 5 0.07 for Cx
versus RCA; LAD & Cx combined 5 3.00 6 0.89, n 5 816, p , 0.0001 versus RCA. Cp 5 NS for LAD versus Cx; p 5 NS
for LAD versus RCA; p 5 0.05 for Cx versus RCA; LAD & Cx combined 5 68.2 6 16.2%, n 5 816, p 5 NS versus RCA.
CCp 5 NS for LAD versus Cx; p 5 0.03 for LAD versus RCA; p 5 NS for Cx versus RCA; LAD & Cx combined 5 7.6 6
5.5, n 5 306, p 5 0.04 versus RCA. ††p 5 0.004 for LAD versus Cx; p , 0.0001 for LAD versus RCA; p 5 0.05 for Cx versus
RCA; LAD & Cx combined 5 48.7%, n 5 1,042, p , 0.001 versus RCA. The sample size is higher as it includes both patent
and occluded arteries. §p 5 NS for LAD versus Cx; p , 0.0001 for LAD versus RCA; p 5 0.0003 for Cx versus RCA; LAD
& Cx combined 5 39.3 6 21.4, n 5 755, p , 0.0001 versus RCA. ¶¶p 5 NS for LAD versus Cx; p 5 0.008 for LAD versus
RCA; p 5 0.08 for Cx versus RCA; LAD & Cx combined 5 17.0%, n 5 822, p 5 0.004 versus RCA. ‡p 5 0.01 for LAD
versus Cx; p , 0.0001 for LAD versus RCA; p 5 0.004 for Cx versus RCA; LAD & Cx combined 5 3.8 6 2.4, n 5 644, p ,
0.0001 versus RCA. **p , 0.0001 for LAD versus Cx; p , 0.0001 for LAD versus RCA; p , 0.0001 for Cx versus RCA; LAD
& Cx combined 5 11.1 6 3.4, n 5 661, p , 0.0001 versus RCA. ¶p , 0.0001 for LAD versus Cx; p , 0.0001 for LAD versus
RCA; p , 0.0001 for Cx versus RCA; LAD & Cx combined 5 74.6 6 13.2, n 5 527, p , 0.0001 versus RCA. ¥p , 0.0001
for LAD versus Cx; p , 0.0001 for LAD versus RCA; p 5 NS for Cx versus RCA; LAD & Cx combined 5 15.6%, n 5 784,
p , 0.001 versus RCA. ‡‡p 5 NS for LAD versus Cx; p 5 NS for LAD versus RCA; p 5 NS for Cx versus RCA; LAD &
Cx combined 5 121.5 6 20.3, n 5 178, p 5 NS versus RCA. §§p 5 NS for LAD versus Cx; p 5 0.02 for LAD versus RCA;
p 5 NS for Cx versus RCA; LAD & Cx combined 5 19.5 6 8.0, n 5 66, p 5 0.02 versus RCA. ¥¥p 5 NS for LAD versus
Cx; p 5 0.06 for LAD versus RCA; p 5 0.002 for Cx versus RCA; LAD & Cx combined 5 32.7 6 26.3, n 5 117, p 5 0.002
versus RCA.
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The relief of the residual stenosis by conventional PTCA
and the scaffolding provided by intracoronary stent place-
ment present unique opportunities to examine the potential
role of the residual stenosis and intraluminal obstruction to
flow delays following thrombolysis. Both rescue and adjunc-
tive PTCA of the residual stenosis at 90 to 120 min largely
normalized discrepancies in pre-PTCA frame counts be-
tween the TIMI flow grades. In a paired analysis, adjunctive
and rescue angioplasty restored flow in culprit vessels at a
rate nearly identical to that of nonculprit arteries in the
setting of AMI (30.5 frames each). These observations
should not, however, be interpreted as demonstrating that
PTCA completely restores “normal” flow. It is important to
note that post-PTCA CTFCs and nonculprit CTFCs of 30
frames are both abnormally slowed, and they are approxi-
mately 45% slower (p , 0.001) than the CTFC of 21
frames previously reported in patients without AMI and
normal flow (8). It is notable that the flow in nonculprit
arteries was slower in those patients with TIMI flow grade
2 in the culprit artery than in those patients with an
occluded culprit artery. The underlying cause of this asso-
ciation is unclear, but it may represent the impact of
reperfusion injury (which had not occurred in the occluded
arteries) or a local reflex that is activated in arteries that
achieve patency.
Despite only a 16.4% residual diameter stenosis and the
relief of intraluminal obstruction that would be anticipated
following stent placement, flow was persistently slowed to
nearly 26 frames (vs. 21 frames without myocardial infarc-
tion), and likewise 34% of stented vessels had abnormal flow
with a CTFC $28 (the 95th percentile of the previously
defined upper limit of normal). This persistent abnormality
in flow is unlikely to be due to either the residual stenosis or
intraluminal obstruction and may represent either the con-
tribution of downstream microvascular resistance, or the
slowing of flow due to hemodynamic compromise, a reflex
or reduced oxygen consumption in infarcted or ischemic
tissue. Whatever the mechanism mediating this persistent
flow delay, those patients with persistently abnormal flow
following relief of the stenosis by stenting did have a higher
mortality.
Differences between the left and right coronary systems
following successful thrombolysis. The CTFCs were
slower and the rates of TIMI flow grade 3 were lower for
the left system than the right system. Of note, the length of
the culprit artery distal to left-system lesions was longer, and
a greater percentage of the vessel lay distal to the culprit
stenosis in left-system lesions (Fig. 2). It could be speculated
that slower flow in the left system may be related to more
extensive necrosis and increased myocardial edema as a
result of the large myocardial mass subtended by the longer
arteries. Perhaps another cause of slower flow in the left
system is extravascular compression of intramyocardial ar-
terioles during left ventricular systole (18–20). Coronary
blood flow in the RCA is relatively independent of the
phase of the cardiac cycle (21). The relatively thicker wall,
the increased wall thickening during systolic contraction
and the higher intracavitary pressures of the left ventricle
may all produce higher intramyocardial pressure (22,23)
than is observed in the thinner-walled right ventricle, which
is also subjected to lower filling pressures.
Moreover, myocardial edema secondary to injury may
further increase these systolic compressive forces acting
upon arterioles in the left ventricular system. Indeed, the
incidence of systolic flow reversal in this study was highest
in LADs. Given these complex interrelationships among
flow, infarct artery location and myocardium at risk, analy-
Figure 2. Shown is a cumulative distribution function of the distance of culprit lesions from the ostium in the setting of acute myocardial
infarction. On the y-axis is the percentage of culprit lesions located within any given distance from the ostium shown on the x-axis. A
greater percentage of LAD and circumflex culprit lesions lie closer to the ostium compared to the RCA.
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ses comparing the clinical, enzymatic, ventriculographic or
electrocardiographic outcomes of the various TIMI flow
grades should correct for the fact that LAD and left-system
locations are both associated with a higher incidence of
TIMI flow grade 2 (8).
Study limitations. The TIMI frame counting technique
was introduced when the TIMI 4 trial was one-third
completed. Following the prospective utilization of the
CTFC method in the TIMI 10A and 10B trials, the CTFC
was evaluable in 97.3% of open arteries at 90 min (739/760).
Hemodynamic data from the TIMI 4, 10A and 10B trials
were not available, and assessment of the underlying effects
of hemodynamic variables on culprit artery flow was based
upon data from the TIMI 14 trial alone. Given the multiple
variables that were analyzed in the present study, it is
possible that some spurious results may have emerged.
However, many of the p values in this study are below the
0.01 level, indicating that they are unlikely to have arisen by
chance. The majority of the univariate correlates were
validated in two random cohorts of the dataset, and the
multivariable model of 90-min flow was validated in both
random cohorts.
Recently we have demonstrated that when the force of
injection is varied between the 10th and 90th percentiles for
human injection rates, the CTFC may change by approxi-
mately two frames (24). Other investigators have recently
reported that the TIMI frame counting method is very
reproducible, with a coefficient of correlation of .0.95
between observers and differences between observers of ,2
frames (25). French et al. (26–28) have likewise reported
mean differences between observers of 0.75 frames. Al-
though the TIMI frame count is a measure of time, it does
not account for vessel length or volume, and it is therefore
only an index of coronary velocity and flow. More direct
measurements of flow determination through ancillary
methods, such as positron emission tomography scanning,
Doppler, or magnetic resonance imaging flow, are needed to
verify these observations.
Aside from protocol-mandated nitrate administration,
this study did not control for drug effect, and it is possible
that other drugs (beta-blockers, calcium channel blockers,
adenosine, sedatives) may have also modulated coronary
flow globally. Preliminary pharmacologic data from Grego-
rini et al. (29) indicate that PTCA in AMI improves culprit
flow from 47 to 38 frames, and stenting transiently improves
the culprit CTFC to 23 frames. However, 15 min later the
culprit artery CTFC slowed to 38 frames (29). Infusion of
the alpha-adrenergic blocker phentolamine reaccelerated
the CTFC to 17 frames (29). There was an association
between culprit and nonculprit flows, and the investigators
concluded that neural mechanisms may be responsible for
the simultaneous slowing in both culprit and nonculprit
vessels. Similar persistent slowing of culprit flow following
stent placement has been reported by the PAMI (Primary
Angioplasty in Myocardial Infarction) investigators, who
have shown that patients with TIMI flow grade 3 before the
stent placement have a CTFC of 26 following stent place-
ment, and those patients with TIMI flow grade 2 before the
stenting have a post-stent CTFC of 36 (30).
Conclusions. Lumen geometry is not the sole determinant
of coronary blood flow at 90 min following thrombolysis.
Other predictors of slowed 90-min flow include left coro-
nary artery location, the late achievement of patency after
60 min, the presence of a pulsatile flow pattern, thrombus,
a greater extent of myocardium subtended by the culprit
artery and hemodynamic perturbations. Also, PTCA of the
residual stenosis improves flow, but flow is persistently
delayed to approximate that in the nonculprit artery. Fol-
lowing relief of the stenosis by stenting, approximately
one-third of patients treated with thrombolysis still have a
persistent flow delay of $28 frames. A persistent blood flow
abnormality following relief of the stenosis by stenting
carries a poor prognosis.
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